BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yendamuri S, Malhotra U, Hennon M, Miller A, Groman A, Halloon A, Reid ME. Clinical characteristics of adenosquamous esophageal carcinoma. J Gastrointest Oncol. 2017;8:89-95. [PMID: 28280613 DOI: 10.21037/jgo.2016.12.03] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Han H, Luo XD, Shao LQ. A population-based analysis of adenosquamous carcinoma of the salivary gland. Gland Surg 2021;10:645-55. [PMID: 33708547 DOI: 10.21037/gs-20-675] [Reference Citation Analysis]
2 Schizas D, Kapsampelis P, Mylonas KS MD. Adenosquamous Carcinoma of the Esophagus: A Literature Review. J Transl Int Med. 2018;6:70-73. [PMID: 29984200 DOI: 10.2478/jtim-2018-0014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
3 Jin Z, Holubek M, Sukov WR, Sattler CA, Wiktor AE, Jenkins RB, Wu TT, Yoon HH. Identification of Adenosquamous Carcinoma as a Rare Aggressive HER2-negative Subgroup of Esophageal/Gastroesophageal Junction Adenocarcinoma. Am J Clin Oncol 2019;42:190-5. [PMID: 30516569 DOI: 10.1097/COC.0000000000000495] [Reference Citation Analysis]
4 Lam AK. Updates on World Health Organization classification and staging of esophageal tumors: implications for future clinical practice. Hum Pathol 2021;108:100-12. [PMID: 33157124 DOI: 10.1016/j.humpath.2020.10.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Liu GY, Zhang JX, Rong L, Nian WD, Nian BX, Tian Y. Esophageal superficial adenosquamous carcinoma resected by endoscopic submucosal dissection: A rare case report. World J Clin Cases 2021; 9(6): 1336-1342 [PMID: 33644200 DOI: 10.12998/wjcc.v9.i6.1336] [Reference Citation Analysis]
6 Ge Y, Lin L, Ma X, Luo D, Shi L, Jiang M, Fan H, He Y, Yang L, Xu Z. Adenosquamous Carcinoma of the Stomach: A Population-based Study from the SEER Database. J Cancer 2019;10:5705-13. [PMID: 31737107 DOI: 10.7150/jca.29162] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
7 Fukai H, Koide N, Yanagisawa N, Koyama Y, Kitagawa N, Ogihara Y, Ohya M. A case report of adenosquamous carcinoma of the esophagogastric junction. Surg Case Rep 2022;8:82. [PMID: 35503581 DOI: 10.1186/s40792-022-01441-6] [Reference Citation Analysis]
8 Gamboa AC, Meyer BI, Switchenko JM, Rupji M, Lee RM, Turgeon MK, Russell MC, Cardona K, Kooby DA, Maithel SK, Shah MM. Should adenosquamous esophageal cancer be treated like adenocarcinoma or squamous cell carcinoma? J Surg Oncol 2020;122:412-21. [PMID: 32462769 DOI: 10.1002/jso.25990] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Li HS, He T, Yang LL. Adenosquamous carcinoma of the digestive system: a literature review. Scand J Gastroenterol 2020;55:1268-76. [PMID: 33070641 DOI: 10.1080/00365521.2020.1832571] [Reference Citation Analysis]
10 Matsuoka K, Hada M, Ohmori H, Yajima A, Nadaya T, Watanabe H, Nakagomi H, Oyama T. A long-term survival case with recurrent esophageal adenosquamous carcinoma. Int Cancer Conf J 2021;10:191-6. [PMID: 34221830 DOI: 10.1007/s13691-021-00473-3] [Reference Citation Analysis]
11 Fujiwara Y, Fukuda S, Tsujie M, Kitani K, Yukawa M, Inoue M, Watanabe Y, Higashida M, Kubota H, Okada T, Tsuruta A, Ueno T. Clinical significance of preoperative chemoradiotherapy for advanced esophageal cancer, evaluated by propensity score matching and weighting of inverse probability of treatment. Mol Clin Oncol 2019;10:575-82. [PMID: 31086666 DOI: 10.3892/mco.2019.1843] [Reference Citation Analysis]
12 Sachdeva UM, Shimonosono M, Flashner S, Cruz-Acuña R, Gabre JT, Nakagawa H. Understanding the cellular origin and progression of esophageal cancer using esophageal organoids. Cancer Lett 2021;509:39-52. [PMID: 33838281 DOI: 10.1016/j.canlet.2021.03.031] [Reference Citation Analysis]
13 Zhang G, Wu B, Wang X, Li J. Second primary malignancy in patients with esophageal adenocarcinoma and squamous cell carcinoma. Medicine (Baltimore) 2019;98:e17083. [PMID: 31490413 DOI: 10.1097/MD.0000000000017083] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Qian H, Ji X, Liu C, Dang Y, Li X, Zhang G. Clinical Characteristics, Prognosis, and Nomogram for Esophageal Cancer Based on Adenosquamous Carcinoma: A SEER Database Analysis. Front Oncol 2021;11:603349. [PMID: 33981595 DOI: 10.3389/fonc.2021.603349] [Reference Citation Analysis]
15 Chen SB, Liu DT, Chen YP. Surgical resection for esophageal adenosquamous carcinoma: an analysis of 56 cases. World J Surg Oncol 2022;20:143. [PMID: 35509082 DOI: 10.1186/s12957-022-02607-0] [Reference Citation Analysis]
16 Sun Y, Wang J, Li Y, Pan S, Yang T, Sun X, Wang Y, Shi X, Zhao X, Zhang X. Nomograms to predict survival rates for esophageal cancer patients with malignant behaviors based on ICD-0-3. Future Oncol 2019;15:121-32. [PMID: 30232909 DOI: 10.2217/fon-2018-0493] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]